2018-2025 Tourette Syndrome Drug Report on Global and United States Market, Status and Forecast, by Players, Types and Applications

April 2018 | 128 pages | ID: 2FC4EE25ED1EN
QYResearch

Abstracts

SUMMARY

This report studies the Tourette Syndrome Drug market status and outlook of global and United States, from angles of players, regions, product types and end industries; this report analyzes the top players in global and United States market, and splits the Tourette Syndrome Drug market by product type and application/end industries.

The global Tourette Syndrome Drug market is valued at XX million USD in 2017 and is expected to reach XX million USD by the end of 2025, growing at a CAGR of XX% between 2017 and 2025.

The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.

North America, especially the United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Tourette Syndrome Drug.

United States plays an important role in global market, with market size of xx million USD in 2017 and will be xx million USD in 2025, with a CAGR of XX.

Geographically, this report is segmented into several key regions, with sales, revenue, market share (%) and growth Rate (%) of Tourette Syndrome Drug in these regions, from 2013 to 2025 (forecast), covering

• United States
• North America
• Europe
• Asia-Pacific
• South America
• Middle East and Africa

The major players in global and United States market, including

• Abide Therapeutics Inc
• Catalyst Pharmaceuticals Inc
• Neurocrine Biosciences Inc
• Psyadon Pharmaceuticals Inc
• Reviva Pharmaceuticals Inc
• Synchroneuron Inc
• Teva Pharmaceutical Industries Ltd
• Therapix Biosciences Ltd

On the basis of product, the market is primarily split into

• AZD-5213
• CPP-115
• Dutetrabenazine ER
• Ecopipam Hydrochloride
• Others

On the basis on the end users/application, this report covers

• Research Center
• Hospital
• Clinic
• Others

Contents

2018-2025 TOURETTE SYNDROME DRUG REPORT ON GLOBAL AND UNITED STATES MARKET, STATUS AND FORECAST, BY PLAYERS, TYPES AND APPLICATIONS

1 METHODOLOGY AND DATA SOURCE

1.1 Methodology/Research Approach
  1.1.1 Research Programs/Design
  1.1.2 Market Size Estimation
  1.1.3 Market Breakdown and Data Triangulation
1.2 Data Source
  1.2.1 Secondary Sources
  1.2.2 Primary Sources
1.3 Disclaimer

2 TOURETTE SYNDROME DRUG MARKET OVERVIEW

2.1 Tourette Syndrome Drug Product Overview
2.2 Tourette Syndrome Drug Market Segment by Type
  2.2.1 AZD-5213
  2.2.2 CPP-115
  2.2.3 Dutetrabenazine ER
  2.2.4 Ecopipam Hydrochloride
  2.2.5 Others
2.3 Global Tourette Syndrome Drug Product Segment by Type
  2.3.1 Global Tourette Syndrome Drug Sales (K Pcs) and Growth (%) by Type (2013, 2017 and 2025)
  2.3.2 Global Tourette Syndrome Drug Sales (K Pcs) and Market Share (%) by Type (2013-2018)
  2.3.3 Global Tourette Syndrome Drug Revenue (Million USD) and Market Share (%) by Type (2013-2018)
  2.3.4 Global Tourette Syndrome Drug Price (USD/Pcs) by Type (2013-2018)
2.4 United States Tourette Syndrome Drug Product Segment by Type
  2.4.1 United States Tourette Syndrome Drug Sales (K Pcs) and Growth by Type (2013, 2017 and 2025)
  2.4.2 United States Tourette Syndrome Drug Sales (K Pcs) and Market Share by Type (2013-2018)
  2.4.3 United States Tourette Syndrome Drug Revenue (Million USD) and Market Share by Type (2013-2018)
  2.4.4 United States Tourette Syndrome Drug Price (USD/Pcs) by Type (2013-2018)

3 TOURETTE SYNDROME DRUG APPLICATION/END USERS

3.1 Tourette Syndrome Drug Segment by Application/End Users
  3.1.1 Research Center
  3.1.2 Hospital
  3.1.3 Clinic
  3.1.4 Others
3.2 Global Tourette Syndrome Drug Product Segment by Application
  3.2.1 Global Tourette Syndrome Drug Sales (K Pcs) and CGAR (%) by Application (2013, 2017 and 2025)
  3.2.2 Global Tourette Syndrome Drug Sales (K Pcs) and Market Share (%) by Application (2013-2018)
3.3 United States Tourette Syndrome Drug Product Segment by Application
  3.3.1 United States Tourette Syndrome Drug Sales (K Pcs) and CGAR (%) by Application (2013, 2017 and 2025)
  3.3.2 United States Tourette Syndrome Drug Sales (K Pcs) and Market Share (%) by Application (2013-2018)

4 TOURETTE SYNDROME DRUG MARKET STATUS AND OUTLOOK BY REGIONS

4.1 Global Market Status and Outlook by Regions
  4.1.1 Global Tourette Syndrome Drug Market Size and CAGR by Regions (2013, 2017 and 2025)
  4.1.2 North America
  4.1.3 Asia-Pacific
  4.1.4 Europe
  4.1.5 South America
  4.1.6 Middle East and Africa
  4.1.7 United States
4.2 Global Tourette Syndrome Drug Sales and Revenue by Regions
  4.2.1 Global Tourette Syndrome Drug Sales (K Pcs) and Market Share (%) by Regions (2013-2018)
  4.2.2 Global Tourette Syndrome Drug Revenue (Million USD) and Market Share (%) by Regions (2013-2018)
  4.2.3 Global Tourette Syndrome Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
  4.2.4 North America Tourette Syndrome Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
  4.2.5 Europe Tourette Syndrome Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
  4.2.6 Asia-Pacific Tourette Syndrome Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
  4.2.7 South America Tourette Syndrome Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
  4.2.8 Middle East and Africa Tourette Syndrome Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
  4.2.9 United States Tourette Syndrome Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)

5 GLOBAL TOURETTE SYNDROME DRUG MARKET COMPETITION BY PLAYERS/MANUFACTURERS

5.1 Global Tourette Syndrome Drug Sales (K Pcs) and Market Share by Players (2013-2018)
5.2 Global Tourette Syndrome Drug Revenue (Million USD) and Share by Players (2013-2018)
5.3 Global Tourette Syndrome Drug Average Price (USD/Pcs) by Players (2013-2018)
5.4 Global Top Players Tourette Syndrome Drug Manufacturing Base Distribution, Sales Area, Product Types
5.5 Tourette Syndrome Drug Market Competitive Situation and Trends
  5.5.1 Tourette Syndrome Drug Market Concentration Rate
  5.5.2 Global Tourette Syndrome Drug Market Share (%) of Top 3 and Top 5 Players
  5.5.3 Mergers & Acquisitions, Expansion

6 UNITED STATES TOURETTE SYNDROME DRUG MARKET COMPETITION BY PLAYERS/MANUFACTURERS

6.1 United States Tourette Syndrome Drug Sales (K Pcs) and Market Share by Players (2013-2018)
6.2 United States Tourette Syndrome Drug Revenue (Million USD) and Share by Players (2013-2018)
6.3 United States Tourette Syndrome Drug Average Price (USD/Pcs) by Players (2013-2018)
6.4 United States Tourette Syndrome Drug Market Share (%) of Top 3 and Top 5 Players

7 TOURETTE SYNDROME DRUG PLAYERS/MANUFACTURERS PROFILES AND SALES DATA

7.1 Abide Therapeutics Inc
  7.1.1 Company Basic Information, Manufacturing Base and Competitors
  7.1.2 Tourette Syndrome Drug Product Category, Application and Specification
    7.1.2.1 Product A
    7.1.2.2 Product B
  7.1.3 Abide Therapeutics Inc Tourette Syndrome Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
  7.1.4 Main Business/Business Overview
7.2 Catalyst Pharmaceuticals Inc
  7.2.1 Company Basic Information, Manufacturing Base and Competitors
  7.2.2 Tourette Syndrome Drug Product Category, Application and Specification
    7.2.2.1 Product A
    7.2.2.2 Product B
  7.2.3 Catalyst Pharmaceuticals Inc Tourette Syndrome Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
  7.2.4 Main Business/Business Overview
7.3 Neurocrine Biosciences Inc
  7.3.1 Company Basic Information, Manufacturing Base and Competitors
  7.3.2 Tourette Syndrome Drug Product Category, Application and Specification
    7.3.2.1 Product A
    7.3.2.2 Product B
  7.3.3 Neurocrine Biosciences Inc Tourette Syndrome Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
  7.3.4 Main Business/Business Overview
7.4 Psyadon Pharmaceuticals Inc
  7.4.1 Company Basic Information, Manufacturing Base and Competitors
  7.4.2 Tourette Syndrome Drug Product Category, Application and Specification
    7.4.2.1 Product A
    7.4.2.2 Product B
  7.4.3 Psyadon Pharmaceuticals Inc Tourette Syndrome Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
  7.4.4 Main Business/Business Overview
7.5 Reviva Pharmaceuticals Inc
  7.5.1 Company Basic Information, Manufacturing Base and Competitors
  7.5.2 Tourette Syndrome Drug Product Category, Application and Specification
    7.5.2.1 Product A
    7.5.2.2 Product B
  7.5.3 Reviva Pharmaceuticals Inc Tourette Syndrome Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
  7.5.4 Main Business/Business Overview
7.6 Synchroneuron Inc
  7.6.1 Company Basic Information, Manufacturing Base and Competitors
  7.6.2 Tourette Syndrome Drug Product Category, Application and Specification
    7.6.2.1 Product A
    7.6.2.2 Product B
  7.6.3 Synchroneuron Inc Tourette Syndrome Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
  7.6.4 Main Business/Business Overview
7.7 Teva Pharmaceutical Industries Ltd
  7.7.1 Company Basic Information, Manufacturing Base and Competitors
  7.7.2 Tourette Syndrome Drug Product Category, Application and Specification
    7.7.2.1 Product A
    7.7.2.2 Product B
  7.7.3 Teva Pharmaceutical Industries Ltd Tourette Syndrome Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
  7.7.4 Main Business/Business Overview
7.8 Therapix Biosciences Ltd
  7.8.1 Company Basic Information, Manufacturing Base and Competitors
  7.8.2 Tourette Syndrome Drug Product Category, Application and Specification
    7.8.2.1 Product A
    7.8.2.2 Product B
  7.8.3 Therapix Biosciences Ltd Tourette Syndrome Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
  7.8.4 Main Business/Business Overview

8 TOURETTE SYNDROME DRUG MANUFACTURING COST, INDUSTRIAL CHAIN AND DOWNSTREAM BUYERS

8.1 Tourette Syndrome Drug Key Raw Materials Analysis
  8.1.1 Key Raw Materials
  8.1.2 Price Trend of Key Raw Materials
  8.1.3 Key Suppliers of Raw Materials
  8.1.4 Market Concentration Rate of Raw Materials
8.2 Proportion of Manufacturing Cost Structure
  8.2.1 Raw Materials
  8.2.2 Labor Cost
  8.2.3 Manufacturing Expenses
8.3 Tourette Syndrome Drug Industrial Chain Analysis
8.4 Downstream Buyers in United States

9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS AND MARKET EFFECT FACTORS

9.1 Marketing Channel
  9.1.1 Direct Marketing
  9.1.2 Indirect Marketing
  9.1.3 Marketing Channel Development Trend
9.2 Distributors in Untied States
9.3 Market Effect Factors Analysis
  9.3.1 Economic/Political Environmental Change
  9.3.2 Downstream Demand Change
  9.3.3 Technology Progress in Related Industry
  9.3.4 Substitutes Threat

10 GLOBAL TOURETTE SYNDROME DRUG MARKET FORECAST

10.1 Global Tourette Syndrome Drug Sales, Revenue Forecast (2018-2025)
  10.1.1 Global Tourette Syndrome Drug Sales (K Pcs) and Growth Rate (%) Forecast (2018-2025)
  10.1.2 Global Tourette Syndrome Drug Revenue (Million USD) and Growth Rate (%) Forecast (2018-2025)
10.2 United States Tourette Syndrome Drug Market Forecast
  10.2.1 United States Tourette Syndrome Drug Sales (K Pcs) and Growth Rate (%) Forecast (2018-2025)
  10.2.2 United States Tourette Syndrome Drug Revenue (Million USD) and Growth Rate (%) Forecast (2018-2025)
10.3 Global Tourette Syndrome Drug Forecast by Regions
  10.3.1 North America Tourette Syndrome Drug Sales (K Pcs) and Revenue (Million USD) Forecast (2018-2025)
  10.3.2 Europe Tourette Syndrome Drug Sales (K Pcs) and Revenue (Million USD) Forecast (2018-2025)
  10.3.3 Asia-Pacific Tourette Syndrome Drug Sales (K Pcs) and Revenue (Million USD) Forecast (2018-2025)
  10.3.4 South America Tourette Syndrome Drug Sales (K Pcs) and Revenue (Million USD) Forecast (2018-2025)
  10.3.5 Middle East and Africa Tourette Syndrome Drug Sales (K Pcs) and Revenue (Million USD) Forecast (2018-2025)
10.4 Tourette Syndrome Drug Forecast by Type
  10.4.1 Global Tourette Syndrome Drug Sales (K Pcs) and Revenue (Million USD) Forecast by Type (2018-2025)
  10.4.2 United States Tourette Syndrome Drug Sales (K Pcs) and Revenue (Million USD) Forecast by Type (2018-2025)
10.5 Tourette Syndrome Drug Forecast by Application
  10.5.1 Global Tourette Syndrome Drug Sales (K Pcs) Forecast by Application (2018-2025)
  10.5.2 United States Tourette Syndrome Drug Sales (K Pcs) Forecast by Application (2018-2025)

11 RESEARCH FINDINGS AND CONCLUSION

The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources
Figure Tourette Syndrome Drug Product Picture
Figure Global Tourette Syndrome Drug Revenue (Million USD) Status and Outlook (2013-2025)
Figure United States Tourette Syndrome Drug Revenue (Million USD) Status and Outlook (2013-2025)
Figure Product Picture of AZD-5213
Table Major Players of AZD-5213
Figure Global AZD-5213 Sales (K Pcs) and Growth Rate (%)(2013-2018)
Figure Product Picture of CPP-115
Table Major Players of CPP-115
Figure Global CPP-115 Sales (K Pcs) and Growth Rate (%)(2013-2018)
Figure Product Picture of Dutetrabenazine ER
Table Major Players of Dutetrabenazine ER
Figure Global Dutetrabenazine ER Sales (K Pcs) and Growth Rate (%)(2013-2018)
Figure Product Picture of Ecopipam Hydrochloride
Table Major Players of Ecopipam Hydrochloride
Figure Global Ecopipam Hydrochloride Sales (K Pcs) and Growth Rate (%)(2013-2018)
Figure Product Picture of Others
Table Major Players of Others
Figure Global Others Sales (K Pcs) and Growth Rate (%)(2013-2018)
Table Global Tourette Syndrome Drug Sales (K Pcs) and Growth Rate (%) Comparison by Type (2013, 2017 and 2025)
Table Global Tourette Syndrome Drug Sales (K Pcs) by Type (2013-2018)
Table Global Tourette Syndrome Drug Sales Share (%) by Type (2013-2018)
Figure Global Tourette Syndrome Drug Sales Market Share (%) by Type (2013-2018)
Figure Global Tourette Syndrome Drug Sales Market Share (%) by Type in 2017
Table Global Tourette Syndrome Drug Revenue (Million USD) by Type (2013-2018)
Table Global Tourette Syndrome Drug Revenue Share (%) by Type (2013-2018)
Figure Global Tourette Syndrome Drug Revenue Share (%) by Type (2013-2018)
Figure 2017 Global Tourette Syndrome Drug Revenue Market Share (%) by Type
Table Global Tourette Syndrome Drug Price (USD/Pcs) by Type (2013-2018)
Table United States Tourette Syndrome Drug Sales (K Pcs) and Growth Rate (%) Comparison by Type (2013, 2017 and 2025)
Table United States Tourette Syndrome Drug Sales (K Pcs) by Type (2013-2018)
Table United States Tourette Syndrome Drug Sales Share (%) by Type (2013-2018)
Figure United States Tourette Syndrome Drug Sales Market Share (%) by Type (2013-2018)
Figure United States Tourette Syndrome Drug Sales Market Share (%) by Type in 2017
Table United States Tourette Syndrome Drug Revenue (Million USD) by Type (2013-2018)
Table United States Tourette Syndrome Drug Revenue Share (%) by Type (2013-2018)
Figure United States Tourette Syndrome Drug Revenue Share (%)by Type (2013-2018)
Figure 2017 United States Tourette Syndrome Drug Revenue Market Share (%) by Type
Table United States Tourette Syndrome Drug Price (USD/Pcs) by Type (2013-2018)
Figure Research Center Examples
Figure Hospital Examples
Figure Clinic Examples
Figure Others Examples
Table Global Tourette Syndrome Drug Sales (K Pcs) Comparison by Application (2013-2025)
Table Global Tourette Syndrome Drug Sales (K Pcs) by Application (2013-2018)
Table Global Tourette Syndrome Drug Sales Share (%) by Application (2013-2018)
Figure Global Tourette Syndrome Drug Sales Market Share (%) by Application (2013-2018)
Figure Global Tourette Syndrome Drug Sales Market Share (%) by Application in 2017
Table United States Tourette Syndrome Drug Sales (K Pcs) Comparison by Application (2013-2025)
Table United States Tourette Syndrome Drug Sales (K Pcs) by Application (2013-2018)
Table United States Tourette Syndrome Drug Sales Share (%) by Application (2013-2018)
Figure United States Tourette Syndrome Drug Sales Market Share (%) by Application (2013-2018)
Figure United States Tourette Syndrome Drug Sales Market Share (%) by Application in 2017
Table Global Tourette Syndrome Drug Revenue (Million USD) and CAGR Comparison by Regions (2013-2025)
Figure North America Tourette Syndrome Drug Revenue (Million USD) and Growth Rate (%)(2013-2025)
Figure Asia-Pacific Tourette Syndrome Drug Revenue (Million USD) and Growth Rate (%)(2013-2025)
Figure Europe Tourette Syndrome Drug Revenue (Million USD) and Growth Rate (%)(2013-2025)
Figure South America Tourette Syndrome Drug Revenue (Million USD) and Growth Rate (%)(2013-2025)
Figure Middle East and Africa Tourette Syndrome Drug Revenue (Million USD) and Growth Rate (%)(2013-2025)
Figure United States Tourette Syndrome Drug Revenue (Million USD) and Growth Rate (%)(2013-2025)
Table Global Tourette Syndrome Drug Sales (K Pcs) by Regions (2013-2018)
Table Global Tourette Syndrome Drug Sales Market Share (%) by Regions (2013-2018)
Figure Global Tourette Syndrome Drug Sales Market Share (%) by Regions (2013-2018)
Figure 2017 Global Tourette Syndrome Drug Sales Market Share (%) by Regions
Figure 2017 United States Tourette Syndrome Drug Sales Market Share (%) in Global Market
Table Global Tourette Syndrome Drug Revenue (Million USD) by Regions (2013-2018)
Table Global Tourette Syndrome Drug Revenue Market Share (%) by Regions (2013-2018)
Figure Global Tourette Syndrome Drug Revenue Market Share (%) by Regions (2013-2018)
Figure 2017 Global Tourette Syndrome Drug Revenue Market Share (%) by Regions
Figure 2017 United States Tourette Syndrome Drug Revenue Market Share (%) in Global Market
Table Global Tourette Syndrome Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
Table North America Tourette Syndrome Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
Table Europe Tourette Syndrome Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
Table Asia-Pacific Tourette Syndrome Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
Table South America Tourette Syndrome Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
Table Middle East and Africa Tourette Syndrome Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
Table United States Tourette Syndrome Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
Table Global Tourette Syndrome Drug Sales (K Pcs) of Key Players (2013-2018)
Table Global Tourette Syndrome Drug Sales Share (%) by Players (2013-2018)
Figure 2017 Global Tourette Syndrome Drug Sales Share (%) by Players
Figure 2018 Global Tourette Syndrome Drug Sales Share (%) by Players
Table Global Tourette Syndrome Drug Revenue (Million USD) by Players (2013-2018)
Table Global Tourette Syndrome Drug Revenue Share (%) by Players (2013-2018)
Table 2017 Global Tourette Syndrome Drug Revenue Share (%) by Players
Table 2018 Global Tourette Syndrome Drug Revenue Share (%) by Players
Table Global Market Tourette Syndrome Drug Average Price (USD/Pcs) by Players (2013-2018)
Table Global Tourette Syndrome Drug Top Players Manufacturing Base Distribution and Sales Area
Table Global Tourette Syndrome Drug Top Players Product Category
Figure Global Tourette Syndrome Drug Market Share (%) of Top 3 Players
Figure Global Tourette Syndrome Drug Market Share (%) of Top 5 Players
Table United States Tourette Syndrome Drug Sales (K Pcs) by Players (2013-2018)
Table United States Tourette Syndrome Drug Sales Market Share (%) by Players (2013-2018)
Figure 2017 United States Tourette Syndrome Drug Sales Share (%) by Players
Figure 2018 United States Tourette Syndrome Drug Sales Share (%) by Players
Table United States Tourette Syndrome Drug Revenue (Million USD) by Players (2013-2018)
Table United States Tourette Syndrome Drug Revenue Market Share (%) by Players (2013-2018)
Table 2017 United States Tourette Syndrome Drug Revenue Share (%) by Players
Table 2018 United States Tourette Syndrome Drug Revenue Share (%) by Players
Table United States Market Tourette Syndrome Drug Average Price (USD/Pcs) by Players (2013-2018)
Figure United States Tourette Syndrome Drug Market Share (%) of Top 3 Players
Figure United States Tourette Syndrome Drug Market Share (%) of Top 5 Players
Table Abide Therapeutics Inc Basic Information List
Table Abide Therapeutics Inc Tourette Syndrome Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
Figure Abide Therapeutics Inc Tourette Syndrome Drug Sales Growth Rate (2013-2018)
Figure Abide Therapeutics Inc Tourette Syndrome Drug Sales Global Market Share (%)(2013-2018)
Figure Abide Therapeutics Inc Tourette Syndrome Drug Revenue Global Market Share (%)(2013-2018)
Table Catalyst Pharmaceuticals Inc Basic Information List
Table Catalyst Pharmaceuticals Inc Tourette Syndrome Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
Figure Catalyst Pharmaceuticals Inc Tourette Syndrome Drug Sales Growth Rate (2013-2018)
Figure Catalyst Pharmaceuticals Inc Tourette Syndrome Drug Sales Global Market Share (%)(2013-2018)
Figure Catalyst Pharmaceuticals Inc Tourette Syndrome Drug Revenue Global Market Share (%)(2013-2018)
Table Neurocrine Biosciences Inc Basic Information List
Table Neurocrine Biosciences Inc Tourette Syndrome Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
Figure Neurocrine Biosciences Inc Tourette Syndrome Drug Sales Growth Rate (2013-2018)
Figure Neurocrine Biosciences Inc Tourette Syndrome Drug Sales Global Market Share (%)(2013-2018)
Figure Neurocrine Biosciences Inc Tourette Syndrome Drug Revenue Global Market Share (%)(2013-2018)
Table Psyadon Pharmaceuticals Inc Basic Information List
Table Psyadon Pharmaceuticals Inc Tourette Syndrome Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
Figure Psyadon Pharmaceuticals Inc Tourette Syndrome Drug Sales Growth Rate (2013-2018)
Figure Psyadon Pharmaceuticals Inc Tourette Syndrome Drug Sales Global Market Share (%)(2013-2018)
Figure Psyadon Pharmaceuticals Inc Tourette Syndrome Drug Revenue Global Market Share (%)(2013-2018)
Table Reviva Pharmaceuticals Inc Basic Information List
Table Reviva Pharmaceuticals Inc Tourette Syndrome Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
Figure Reviva Pharmaceuticals Inc Tourette Syndrome Drug Sales Growth Rate (2013-2018)
Figure Reviva Pharmaceuticals Inc Tourette Syndrome Drug Sales Global Market Share (%)(2013-2018)
Figure Reviva Pharmaceuticals Inc Tourette Syndrome Drug Revenue Global Market Share (%)(2013-2018)
Table Synchroneuron Inc Basic Information List
Table Synchroneuron Inc Tourette Syndrome Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
Figure Synchroneuron Inc Tourette Syndrome Drug Sales Growth Rate (2013-2018)
Figure Synchroneuron Inc Tourette Syndrome Drug Sales Global Market Share (%)(2013-2018)
Figure Synchroneuron Inc Tourette Syndrome Drug Revenue Global Market Share (%)(2013-2018)
Table Teva Pharmaceutical Industries Ltd Basic Information List
Table Teva Pharmaceutical Industries Ltd Tourette Syndrome Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
Figure Teva Pharmaceutical Industries Ltd Tourette Syndrome Drug Sales Growth Rate (2013-2018)
Figure Teva Pharmaceutical Industries Ltd Tourette Syndrome Drug Sales Global Market Share (%)(2013-2018)
Figure Teva Pharmaceutical Industries Ltd Tourette Syndrome Drug Revenue Global Market Share (%)(2013-2018)
Table Therapix Biosciences Ltd Basic Information List
Table Therapix Biosciences Ltd Tourette Syndrome Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (%)(2013-2018)
Figure Therapix Biosciences Ltd Tourette Syndrome Drug Sales Growth Rate (2013-2018)
Figure Therapix Biosciences Ltd Tourette Syndrome Drug Sales Global Market Share (%)(2013-2018)
Figure Therapix Biosciences Ltd Tourette Syndrome Drug Revenue Global Market Share (%)(2013-2018)
Table Sales Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Tourette Syndrome Drug
Figure Tourette Syndrome Drug Industrial Chain Analysis
Table Major Buyers of Tourette Syndrome Drug
Table Distributors/Traders List
Figure Global Tourette Syndrome Drug Sales (K Pcs) and Growth Rate (%) Forecast (2018-2025)
Figure Global Tourette Syndrome Drug Revenue (Million USD) and Growth Rate (%) Forecast (2018-2025)
Figure United States Tourette Syndrome DrugTourette Syndrome Drug Sales (K Pcs) and Growth Rate (%) Forecast (2018-2025)
Figure United States Tourette Syndrome Drug Revenue (Million USD) and Growth Rate (%) Forecast (2018-2025)
Table Global Tourette Syndrome Drug Sales (K Pcs) Forecast by Regions (2018-2025)
Figure Global Tourette Syndrome Drug Sales Market Share (%) Forecast by Regions (2018-2025)
Figure North America Tourette Syndrome Drug Sales (K Pcs) and Growth Rate (%) Forecast (2018-2025)
Figure North America Tourette Syndrome Drug Revenue and Growth Rate (%) Forecast (2018-2025)
Figure Europe Tourette Syndrome Drug Sales (K Pcs) and Growth Rate (%) Forecast (2018-2025)
Figure Europe Tourette Syndrome Drug Revenue and Growth Rate (%) Forecast (2018-2025)
Figure Asia-Pacific Tourette Syndrome Drug Sales (K Pcs) and Growth Rate (%) Forecast (2018-2025)
Figure Asia-Pacific Tourette Syndrome Drug Revenue and Growth Rate (%) Forecast (2018-2025)
Figure South America Tourette Syndrome Drug Sales (K Pcs) and Growth Rate (%) Forecast (2018-2025)
Figure South America Tourette Syndrome Drug Revenue and Growth Rate (%) Forecast (2018-2025)
Figure Middle East and Africa Tourette Syndrome Drug Sales (K Pcs) and Growth Rate (%) Forecast (2018-2025)
Figure Middle East and Africa Tourette Syndrome Drug Revenue and Growth Rate (%) Forecast (2018-2025)
Table Global Tourette Syndrome Drug Sales (Million USD) Forecast by Type (2018-2025)
Figure Global Tourette Syndrome Drug Sales Market Share (%) Forecast by Type (2018-2025)
Table Global Tourette Syndrome Drug Revenue (Million USD) Forecast by Type (2018-2025)
Figure Global Tourette Syndrome Drug Revenue Market Share (%) Forecast by Type (2018-2025)
Table United States Tourette Syndrome Drug Sales (Million USD) Forecast by Type (2018-2025)
Figure United States Tourette Syndrome Drug Sales Market Share (%) Forecast by Type (2018-2025)
Table United States Tourette Syndrome Drug Revenue (Million USD) Forecast by Type (2018-2025)
Figure United States Tourette Syndrome Drug Revenue Market Share (%) Forecast by Type (2018-2025)
Table Global Tourette Syndrome Drug Sales (K Pcs) Forecast by Application (2018-2025)
Figure Global Tourette Syndrome Drug Sales Forecast by Application (2018-2025)
Table United States Tourette Syndrome Drug Sales (K Pcs) Forecast by Application (2018-2025)
Figure United States Tourette Syndrome Drug Sales Forecast by Application (2018-2025)